Genomic & Biopharma News

Study focuses on benefit of continuous glucose monitoring for diabetes patients on MDI insulin therapy
Dexcom announces the first and only randomised, controlled study focusing solely on the benefit of continuous glucose monitoring (CGM) for diabetes patients on multiple daily injections (MDI) insulin therapy.
News Medical Life Sciences, 2017-01-27 13:20:27

Marginal deficiency of vitamin A in fetus or newborns may lead to Alzheimer's disease in later life
Biochemical reactions that cause Alzheimer's disease could begin in the womb or just after birth if the fetus or newborn does not get enough vitamin A, according to new research from the University of British Columbia.
News Medical Life Sciences, 2017-01-27 13:18:00

Immunobiology of Long Noncoding RNAs
The discovery of long noncoding RNAs (lncRNA) has provided a new perspective on gene regulation in diverse biological contexts. lncRNAs are remarkably versatile molecules that interact with RNA, DNA, or proteins to promote or restrain the expression of protein-coding genes. Activation of immune cells is associated with dynamic changes in expression of genes, the products ...
lncRNA Research and Industry News, 2017-01-27 13:15:36

Study: Personalised risk information and taster sessions double chances of attending stop smoking course
Offering smokers a taster session at an NHS Stop Smoking Service and explaining their personal risk of developing smoking-related diseases doubles their likelihood of attending a stop smoking course, according to a study in The Lancet.
News Medical Life Sciences, 2017-01-27 13:09:50

Lancet study: Advanced MRI doubles detection of aggressive tumours
A study published in The Lancet on 19th January 2017 entitled ‘Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study’ shows that using advanced MRI almost doubles the number of aggressive tumours detected.
News Medical Life Sciences, 2017-01-27 13:07:13

A proof of concept for exosome-based delivery of miRNA in neurodegenerative diseases
Huntington’s disease (HD) is a genetic neurodegenerative disease that is caused by abnormal CAG expansion. Altered microRNA (miRNA) expression also causes abnormal gene regulation in this neurodegenerative disease. The delivery of abnormally downregulated miRNAs might restore normal gene regulation and have a therapeutic effect. Researchers at Seoul National University Hospital have developed an exosome-based delivery ...
Exosome RNA Research & Industry News, 2017-01-27 13:03:45

Comparing RNA-Seq Results from Paired FFPE & Fresh-Frozen Samples
The molecular classification of glioblastoma (GBM) based on gene expression might better explain outcome and response to treatment than clinical factors. Whole transcriptome sequencing using next-generation sequencing platforms is rapidly becoming accepted as a tool for measuring gene expression for both research and clinical use. Fresh frozen (FF) tissue specimens of GBM are difficult to ...
Transcriptome Research & Industry News, 2017-01-27 12:48:09

Chasing Sanofi, Pfizer tees up phase 3 trials for C. diff vaccine
Chasing Sanofi, Pfizer tees up phase 3 trials for C. diff vaccine phil Fri, 01/27/2017 - 07:28
Fierce Biotech, 2017-01-27 12:28:14

After FDA rejection, Novartis pulls Amgen biosim candidate from EMA
After FDA rejection, Novartis pulls Amgen biosim candidate from EMA badams Fri, 01/27/2017 - 07:25
Fierce Biotech, 2017-01-27 12:25:33